[1]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
STRAIN=DBA/2J;
TISSUE=Kidney;
PubMed=8441417 [NCBI, ExPASy, EBI, Israel, Japan]
Aziz N.,
Maxwell M.M.,
St Jacques B.,
Brenner B.M.;
"Downregulation of Ke 6, a novel gene encoded within the major histocompatibility complex, in murine polycystic kidney disease.";
Mol. Cell. Biol. 13:1847-1853(1993).
|
[2]
|
ERRATUM.
Aziz N.,
Maxwell M.M.,
St Jacques B.,
Brenner B.M.;
Mol. Cell. Biol. 13:6614-6614(1993).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
STRAIN=C57BL/6;
DOI=10.1074/jbc.270.42.25213; PubMed=7559658 [NCBI, ExPASy, EBI, Israel, Japan]
Maxwell M.M.,
Nearing J.,
Aziz N.;
"Ke 6 gene. Sequence and organization and aberrant regulation in murine polycystic kidney disease.";
J. Biol. Chem. 270:25213-25219(1995).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=129/SvJ;
Rowen L.,
Qin S.,
Madan A.,
Loretz C.,
James R.,
Dors M.,
Mix L.,
Hall J.,
Lasky S.,
Hood L.;
"Sequence of the mouse major histocomaptibility locus class II region.";
Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
DOI=10.1074/jbc.273.35.22664; PubMed=9712896 [NCBI, ExPASy, EBI, Israel, Japan]
Fomitcheva J.,
Baker M.E.,
Anderson E.,
Lee G.Y.,
Aziz N.;
"Characterization of Ke 6, a new 17beta-hydroxysteroid dehydrogenase, and its expression in gonadal tissues.";
J. Biol. Chem. 273:22664-22671(1998).
|
[6]
|
SUBCELLULAR LOCATION.
DOI=10.1369/jhc.5A6692.2005; PubMed=15923359 [NCBI, ExPASy, EBI, Israel, Japan]
Pelletier G.,
Luu-The V.,
Li S.,
Labrie F.;
"Localization of type 8 17beta-hydroxysteroid dehydrogenase mRNA in mouse tissues as studied by in situ hybridization.";
J. Histochem. Cytochem. 53:1257-1271(2005).
|
[7]
|
ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-67, AND MASS SPECTROMETRY.
TISSUE=Liver;
DOI=10.1016/j.molcel.2006.06.026; PubMed=16916647 [NCBI, ExPASy, EBI, Israel, Japan]
Kim S.C.,
Sprung R.,
Chen Y.,
Xu Y.,
Ball H.,
Pei J.,
Cheng T.,
Kho Y.,
Xiao H.,
Xiao L.,
Grishin N.V.,
White M.,
Yang X.-J.,
Zhao Y.;
"Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.";
Mol. Cell 23:607-618(2006).
|
|
- FUNCTION: Uses estradiol as its preferred substrate.
- CATALYTIC ACTIVITY: Estradiol-17-beta + NAD(P)+ = estrone + NAD(P)H.
- CATALYTIC ACTIVITY: Testosterone + NAD+ = androst-4-ene-3,17-dione + NADH.
- BIOPHYSICOCHEMICAL PROPERTIES:
| Kinetic parameters: |
KM=0.110 µM for estradiol; | | KM=0.422 µM for testosterone; | | KM=0.368 µM for estrone; | | KM=0.360 µM for dihydrotestosterone; | | Vmax=0.405 nmol/min/mg enzyme for estradiol as substrate; | | Vmax=0.123 nmol/min/mg enzyme for testosterone as substrate; | | Vmax=0.186 nmol/min/mg enzyme for estrone as substrate; | | Vmax=0.081 nmol/min/mg enzyme for dihydrotestosterone as substrate; | |
- PATHWAY: Steroid metabolism; estrogen biosynthesis.
- ALTERNATIVE PRODUCTS:
2 named isoforms [FASTA] produced by alternative splicing.
|
| Name | Long |
| Isoform ID | P50171-2 |
| Features which should be applied to build the isoform sequence: VSP_006030. |
|
|
- TISSUE SPECIFICITY: Kidney, liver, testis, ovary, oviduct, uterus, mammary gland, vagina, prostate, clitoral gland and moderately in spleen, heart, dorsal skin, brain and lung.
- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR) family.
|